Human factor VIIa and its complex with soluble tissue factor: evaluation of asymmetry and conformational dynamics by ultracentrifugation and fluorescence anisotropy decay methods

Biochemistry ◽  
1993 ◽  
Vol 32 (12) ◽  
pp. 3005-3012 ◽  
Author(s):  
Evan Waxman ◽  
William R. Laws ◽  
Thomas M. Laue ◽  
Yale Nemerson ◽  
J. B. Alexander Ross
1996 ◽  
Vol 76 (03) ◽  
pp. 361-368 ◽  
Author(s):  
Carrie H Fang ◽  
T-C Lin ◽  
Arabinda Guha ◽  
Yale Nemerson ◽  
William H Konigsberg

SummaryIn an attempt to define sequence elements in human and mouse tissue factor (TF) that are responsible for the species specificity observed in their interaction with human factor VIIa (HVIIa), we constructed human-mouse chimeric TF cDNAs, inserted them into plasmid vectors, and induced their expression in E.coli. Assays for procoagulant activity were carried out with the resulting E. coli lysates using (HVIIa) human and mouse (MVIIa). The ratio of the procoagulant activities, HVIIa/MVIIa, revealed that human TF exon 3 was essential for activity when the TF:VIIa complex was formed with HVIIa. By ligating the maltose binding protein (MBP) gene to TF cDNAs it was possible to construct, express and purify MBP-TF chimeras as well as to estimate their specific activities. With selected MBP-TF chimeras and HVIIa we determined kinetic parameters for the activation of human factor X. Replacement of exon 3 in human TF cDNA with the corresponding exon from mouse TF cDNA resulted in both lower affinity for HVIIa and failure to convert bound HVIIa into a potent protease


Polymer ◽  
1989 ◽  
Vol 30 (1) ◽  
pp. 51-57 ◽  
Author(s):  
Mamadou Fofana ◽  
Valérie Veissier ◽  
Jean Louis Viovy ◽  
Lucien Monnerie

1997 ◽  
Vol 2 (3) ◽  
pp. 171-178 ◽  
Author(s):  
John C.W. Comley ◽  
Alastair Binnie ◽  
Caroline Bonk ◽  
John G. Houston

A homogenous fluorescent HTS for recombinant human factor VIIa (FVIIa) using soluble tissue factor has been developed in 384-well microplates. In this report we discuss our experiences with assay development, liquid handling using a Tomtec Quadra and Matrix PlateMate, fluorescent detection and screening of -200,000 compounds against FVIIa in 384-well plate format. Assays using the entire Helix 864-well plate were prototyped using contact dispensing with a modified Hamilton Microlab 2200. FVIIa was used as a model assay to compare between 96-, 384-, and 864-plate formats in a total assay volume of 100, 25, and 10 μl, respectively. FVIIa was assayed in 864 to the same degree of sensitivity as 384- and 96-well assays and dose-response curves for a standard inhibitor (benzamidine) in the FVIIa assay were identical in all plate formats. Finally, we review the prospects for HTS in 864-well microplates.


1981 ◽  
Vol 13 (1) ◽  
pp. 77-87 ◽  
Author(s):  
Daniel Genest ◽  
Georgette Sabeur ◽  
Philippe Wahl ◽  
Jean-Claude Auchet

2019 ◽  
Vol 21 (24) ◽  
pp. 13368-13369 ◽  
Author(s):  
Hem C. Joshi

In a recent paper published in Physical Chemistry Chemical Physics (Phys. Chem. Chem. Phys., 2018, 20, 2251–2259), Förster resonance energy transfer (FRET) between carbon dots and rhodamine 123 has been reported.


Sign in / Sign up

Export Citation Format

Share Document